Artículos por temáticas

Spotlight on movement disorders: What optogenetics has to offer.

Rossi MA, Calakos N, Yin HH.

Mov Disord. 2015 Apr 15;30(5):624-31. doi: 10.1002/mds.26184.

Deep brain stimulation for movement disorders: update on recent discoveries and outlook on future developments.

Mahlknecht P, Limousin P, Foltynie T.

J Neurol. 2015 Nov;262(11):2583-95. doi: 10.1007/s00415-015-7790-8. Review.

Intrathecal Baclofen therapy in Germany: Proceedings of the IAB-Interdisciplinary Working Group for Movement Disorders Consensus Meeting.

Dressler D, Berweck S, Chatzikalfas A, Ebke M, Frank B, Hesse S, Huber M, Krauss JK, Mücke KH, Nolte A, Oelmann HD, Schönle PW, Schmutzler M, Pickenbrock H, Van der Ven C, Veelken N, Vogel M, Vogt T,

J Neural Transm (Vienna). 2015 Nov;122(11):1573-9. doi: 10.1007/s00702-015-1425-1.

Medication-induced acute dystonic reaction: the challenge of diagnosing movement disorders in the intensive care unit.

Digby G, Jalini S, Taylor S.

BMJ Case Rep. 2015 Sep 21;2015. pii: bcr2014207215. doi: 10.1136/bcr-2014-207215.

Is pineal melatonin released in the third ventricle in humans? A study in movement disorders.

Leston J, Harthé C, Mottolese C, Mertens P, Sindou M, Claustrat B.

Neurochirurgie. 2015 Apr-Jun;61(2-3):85-9. doi: 10.1016/j.neuchi.2013.04.004.

Movement disorders in systemic diseases.

Poewe W, Djamshidian-Tehrani A.

Neurol Clin. 2015 Feb;33(1):269-97. doi: 10.1016/j.ncl.2014.09.015. Review.

[The genetics of antipsychotic-related movement disorders].

Bakker PR, van Os J, van Harten PN.

Tijdschr Psychiatr. 2015;57(2):114-9. Review. Dutch.

[The distinctive features of EMG-activity in early age children with movement disorders].

Zhvanskiĭ ES, Tsyshkova ON, Grishin AA, Ivanenko IuP, Levik IuS, Keshishian ES.

Fiziol Cheloveka. 2015 Jan-Feb;41(1):49-56. Russian.

Radiation-induced camptocormia and dropped head syndrome: Review and case report of radiation-induced movement disorders.

Seidel C, Kuhnt T, Kortmann RD, Hering K.

Strahlenther Onkol. 2015 Oct;191(10):765-70. doi: 10.1007/s00066-015-0857-8. Review.

Speech and voice disorders in patients with psychogenic movement disorders.

Baizabal-Carvallo JF, Jankovic J.

J Neurol. 2015 Nov;262(11):2420-4. doi: 10.1007/s00415-015-7856-7.

Nicotine and Nicotinic Receptor Drugs: Potential for Parkinson's Disease and Drug-Induced Movement Disorders.

Quik M, Bordia T, Zhang D, Perez XA.

Int Rev Neurobiol. 2015;124:247-71. doi: 10.1016/bs.irn.2015.07.005. Review.

How to avoid trivial mistakes during IPG replacement in patients treated with DBS for movement disorders: technical note from 13-years experience.

Latini F, Sensi M, Preda F, Cavallo MA.

Int J Neurosci. 2015;125(10):760-4. doi: 10.3109/00207454.2014.984294.

Human olfactory bulb neural stem cells mitigate movement disorders in a rat model of Parkinson's disease.

Marei HE, Lashen S, Farag A, Althani A, Afifi N, A AE, Rezk S, Pallini R, Casalbore P, Cenciarelli C.

J Cell Physiol. 2015 Jul;230(7):1614-29. doi: 10.1002/jcp.24909.

Movement disorders and other motor abnormalities in adults with 22q11.2 deletion syndrome.

Boot E, Butcher NJ, van Amelsvoort TA, Lang AE, Marras C, Pondal M, Andrade DM, Fung WL, Bassett AS.

Am J Med Genet A. 2015 Mar;167A(3):639-45. doi: 10.1002/ajmg.a.36928.

GRIN1 mutations cause encephalopathy with infantile-onset epilepsy, and hyperkinetic and stereotyped movement disorders.

Ohba C, Shiina M, Tohyama J, Haginoya K, Lerman-Sagie T, Okamoto N, Blumkin L, Lev D, Mukaida S, Nozaki F, Uematsu M, Onuma A, Kodera H, Nakashima M, Tsurusaki Y, Miyake N, Tanaka F, Kato M, Ogata K,

Epilepsia. 2015 Jun;56(6):841-8. doi: 10.1111/epi.12987.